tenk.fyi

Skye Bioscience, Inc.

SKYENasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$55.9M

110.5% YoY

EPS

$-1.41

93.2% YoY

Cash

$5.9M

91.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro